The FDA has approved Bavarian Nordic’s Vimkunya, the first virus-like particle (VLP) chikungunya vaccine for patients over 12 years of age. According to the company, approval was based on strong ...
The building industry, responsible for 40% of global CO2 emissions, is pressured to improve efficiency and sustainability. As ...
Bavarian Nordic sets up a bout with Valneva’s Ixchiq, the former’s Vimkunya already having an edge in population reach.
Okanagan, a region in Canada's British Columbia province, offers great wine, under-the-radar ski hills, and incredible fondue ...
First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger ...
General Knowledge (Video) on MSN6d
What If There Were MORE Nordic Countries?Go to <a href=" to get 96% off lifetime access to 41 languages and start learning today. In this video I explore the concept: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback